Evidence map›Paper›PMID 37813180›Full record

ArticleChest2024

Prospective Evaluation of Venous Excess Ultrasound for Estimation of Venous Congestion.

August Longino, Katie Martin, Katarina Leyba, Gabriel Siegel, Theresa N Thai, Matthew Riscinti, Ivor S Douglas, Edward Gill, Joseph Burke

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Chest, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06714409 narecruitingnot on this map

A Parallel-group, Single-center, Two-arm Treatment Study to Assess the Safety and Effectiveness of Venous Ultrasound Guided Decongestion in Adult Patients Hospitalized with Acute Decompensated Heart Failure.

TypeinterventionalSponsorOslo University HospitalRan2024 to 2025Enrolled180ConditionsCardiorenal Syndrome, Heart Failure, Acute Kidney Injury, Acute Decompensated Heart FailureArmsVExUS guided decongestion
NCT07291778 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Impact of VeXUS-guided Fluid Management in ICU Populations on Renal Function

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2026 to 2028Enrolled100ConditionsAcute Kidney Injury, VExUSArmsFluid Management, No intervention
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Deresuscitation Informed by Ultrasound in Patients With Septic Shock Trial: A Pilot Randomized Controlled Study.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Trial
  3. Abbreviated Point-of-Care-Ultrasound Volume Assessment for Outpatient Hemodialysis Patients.Mayo Clinic proceedings. Innovations, quality & outcomes · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Fluid management methods for severely burned patients: a narrative review.Journal of clinical monitoring and computing · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

August LonginoDepartment of Internal Medicine, University of Colorado Hospital, Aurora. Electronic address: august.longino@cuanschutz.edu.
Katie MartinUniversity of Colorado School of Medicine, University of Colorado, Aurora.
Katarina LeybaDepartment of Internal Medicine, University of Colorado Hospital, Aurora.
Gabriel SiegelDepartment of Emergency Medicine, University of Colorado Hospital, Aurora.
Theresa N ThaiDepartment of Cardiology, University of Colorado, Aurora.
Matthew RiscintiDepartment of Emergency Medicine, University of Colorado Hospital, Aurora.
Ivor S DouglasDepartment of Pulmonary and Critical Care Medicine, Denver Health Medical Center, Denver, CO.
Edward GillDepartment of Cardiology, University of Colorado, Aurora.
Joseph BurkeDepartment of Cardiology, Denver Health Medical Center, Denver, CO.
University of Colorado Hospital · USUniversity of Colorado Anschutz Medical Campus · USDenver Health Medical Center · US

Funding

Colorado StARR Program in Medicine and Pediatrics (CSPMP)R38HL143511 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Steven Herbert Abman, Peter N. Buttrick · 2020 to 2026
$2.7M
NHLBI NIH HHS R38 HL143511
6 · The paper itself

Abstract

backgroundVenous excess ultrasound (VExUS) is a novel ultrasound technique previously reported as a noninvasive measure of venous congestion and predictor of cardiorenal acute kidney injury. RESEARCH QUESTION: Are there associations between VExUS grade and cardiac pressures measured by right heart catheterization (RHC) and cardiac biomarkers and clinical outcomes in patients undergoing RHC? STUDY DESIGN AND

methodsWe conducted a prospective cohort study at the Denver Health Medical Center from December 20, 2022, to March 25, 2023. All patients undergoing RHC underwent a blinded VExUS assessment prior to their procedure. Multivariable regressions were conducted to assess relationships between VExUS grade and cardiac pressures, biomarkers, and changes in weight among patients with heart failure, a proxy for diuretic success. Receiver operating characteristic curve and area under the curve (AUC) were derived for VExUS, inferior vena cava (IVC) diameter, and IVC collapsibility index (ICI) to predict right atrial pressure (RAP) > 10 and < 7 mm Hg.

resultsAmong 81 patients, 45 of whom were inpatients, after adjusting for age, sex, and Charlson Comorbidity Index, there were significant relationships between VexUS grade of 2 (β = 4.8; 95% CI, 2.6-7.1; P < .01) and 3 (β = 11; 95% CI, 8.9-14; P < .01) and RAP, VExUS grade of 2 (β = 6.8; 95% CI, 0.16-13; P = .045) and 3 (β = 15; 95% CI, 7.3-22; P < .01) and mean pulmonary artery pressure, and VExUS grade of 2 (β = 7.0; 95% CI, 3.9-10; P < .01) and 3 (β = 13; 95% CI, 9.5-17; P < .01) and pulmonary capillary wedge pressure. AUC values for VExUS, IVC diameter, and ICI as predictors of RAP > 10 mm Hg were 0.9 (95% CI, 0.83-0.97), 0.77 (95% CI, 0.68-0.88), and 0.65 (95% CI, 0.52-0.78), respectively. AUC values for VExUS, IVC diameter, and ICI as predictors of RAP < 7 mm Hg were 0.79 (95% CI, 0.70-0.87), 0.74 (95% CI, 0.64-0.84), and 0.62 (95% CI, 0.49-0.76), respectively. In a subset of 23 patients with heart failure undergoing diuresis, there was a significant association between VExUS grade 3 and change in weight between time of RHC and discharge (P = .025).

interpretationAlthough more research is required, VExUS has the potential to increase diagnostic and therapeutic capabilities of physicians at the bedside and increase our understanding of the underappreciated problem of venous congestion.

Indexed as

Heart FailureHyperemiaBiomarkersHumansProspective StudiesUltrasonographyVena Cava, InferiorBiomarkersacute kidney injurydiuretic responsivenesshemodynamicsultrasoundvenous congestionvolume assessment

Identifiers

PMID37813180
PMCPMC11317813
OpenAlexW4387432546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.